Drug Discovery and Development
The experts listed here were chosen to represent the principal fields of research at RTI because of their professional experience, published writings, and peer recognition. To request an interview or an expert opinion of any of these individuals, please contact either Lisa Bistreich (919-316-3596; lbistreich@rti.org) or Patrick Gibbons (919-541-6136; pgibbons@rti.org).
The following experts are active in the field of Drug Discovery & Development.
Related Experts
Stephen M. Beard
Health Economics
Disease Management
Decision Analytic Modeling and Value Strategy Development in Health Care
Disease Management
Decision Analytic Modeling and Value Strategy Development in Health Care
Irma M. Grossi
Preclinical Drug Development
Metastasis Models
Eicosanoid Metabolism
Integrins and Cell Adhesion
Metastasis Models
Eicosanoid Metabolism
Integrins and Cell Adhesion
Josephine A. Mauskopf
Health Economics
Patient-Reported Outcomes
Health Care Interventions
Pharmacoeconomics
Patient-Reported Outcomes
Health Care Interventions
Pharmacoeconomics
Lori D. McLeod
Health Status and Quality of Life Assessment
Patient-Reported Outcomes
Health Outcomes Strategy
Psychometrics
Patient-Reported Outcomes
Health Outcomes Strategy
Psychometrics
Kenneth J. Rothman
Pharmacoepidemiology
Birth Defects
Cancer
Epidemiologic Study Design and Data Analysis
Birth Defects
Cancer
Epidemiologic Study Design and Data Analysis
Rochelle W. Tyl
Regulatory Toxicology
Developmental and Reproductive Toxicology
Endocrine Toxicology
Developmental Neurotoxicology
Developmental and Reproductive Toxicology
Endocrine Toxicology
Developmental Neurotoxicology